Q32 Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	451	41	42	-	-	-
Market Cap Growth	1942.82%	-2.51%	-	-	-	-
Enterprise Value	350	9	-25	-	-	-
Last Close Price	15.15	3.32	3.44	-	-	-
PE Ratio	6.67	1.37	-	-	-	-
PS Ratio	8.39	0.76	-	-	-	-
PB Ratio	3.40	0.97	7.38	-	-	-
P/TBV Ratio	4.26	0.97	7.38	-	-	-
EV/Sales Ratio	6.51	0.16	-	-	-	-
EV/EBITDA Ratio	16.04	0.51	-	-	-	-
EV/EBIT Ratio	16.31	0.52	-	-	-	-
Debt / Equity Ratio	0.05	0.37	3.33	-0.71	-2.32	0.22
Debt / EBITDA Ratio	0.23	0.81	-	-	-	-
Net Debt / Equity Ratio	-0.95	-0.78	-10.41	-0.35	-0.04	-1.23
Net Debt / EBITDA Ratio	-4.63	-1.91	0.90	-0.53	-0.02	0.74
Net Debt / FCF Ratio	5.09	0.98	0.87	-1.35	-0.06	0.82
Asset Turnover	0.59	0.70	-	-	0.14	-
Quick Ratio	19.78	4.31	4.77	1.87	0.78	4.60
Current Ratio	20.30	4.85	4.97	2.04	0.81	4.71
Return on Equity (ROE)	72.14%	125.06%	-	-	-2884.70%	-
Return on Assets (ROA)	14.74%	13.71%	-59.28%	-55.42%	-50.59%	-
Return on Capital Employed (ROCE)	19.40%	33.50%	-87.10%	-146.50%	-1003.50%	-131.40%
Earnings Yield	7.49%	73.00%	-113.92%	-	-	-
FCF Yield	-4.40%	-82.11%	-161.78%	-	-	-
Buyback Yield / Dilution	-21.91%	-27.51%	-2666.77%	95.03%	-8.57%	-

SEC Filings: 10-K · 10-Q